Personal Information
Organization / Workplace
Denville United States
Industry
Medical / Health Care / Pharmaceuticals
Website
www.i3Health.com
About
i3 Health's mission is to enhance the proficiency of the multidisciplinary cancer care team by providing evidence-based, fair-balanced CME/NCPD-approved activities that address identified professional practice gaps and unmet educational needs.
Tags
oncology
free cme
oncology nurse
cme
oncology physician
oncology education
oncology nursing society
ncpd
oncology cme
hematology
oncology nursing
continuing medical education
oncology fellows
cancer
oncologist
toxicity breast cancer
breast cancer
supportive care
breast cancer therapies
cpe
oncology and hematology
md
managing side effects
md anderson cancer center
multiple myeloma
prostate cancer
castration-resistant prostate cancer
crpc
nurse
physician
hematology fellow
physician education
treatment of multiple myeloma
ucla health
adverse event
immune thrombocytopenia
lung cancer
targeted therapy
metastatic breast cancer
immunotherapy
hodgkin lymphoma
tanya dorff
follicular lymphoma
hematologist
cancer education
nursing education
free ce
free ncpd
assuntina sacco
hnscc
head and neck scc
head and neck cancer
medical oncology
genitourinary cancer
urology
np
immune checkpoint inhibitors
mantle cell lymphoma
virtual tumor board
non small cell lung cancer
nsclc
anas younes
relapsed follicular lymphoma
sara tolaney
triple negative breast cancer
gastrointestinal oncology
gastric cancer
accme
tumor stage
radiation oncologist
clinical trials
early stage nsclc
msn
blanca ledezma
best practices
cancer immunotherapy
immune related adverse events
georgetown university medicine
catherine m broome
anemia cold-induced
strategies for anemia
safety and efficacy
diagnosis
cold agglutinin disease
attending faculty
faculty
hematology nurse
treatment
pathology
soft tissue sarcoma
advanced soft tissue sarcoma
education
breast pathology'
ira bleiweiss
dana farber cancer
tnbc therapies
breast oncology
spero cataland
acquired thrombotic thrombocyt
nanobodies in attp
anti-von willebrand factor
trials
attp
memorial sloan kettering
urvi shah
monoclonal antibodies
ndmm treatment
continuing education
medical education
free cne
metastatic disease
christopher lieu
colorectal cancer
her2-positive colorectal cance
bispecific t-cell
t-cell therapies
bcma-directed antibody -drug c
fred hutchinson cancer center
rahul banerjee
teaching resource
i3 health
ulka vaishampayan
oncology ncpd
mayo clinic
dr kelley rone
brigham women's hospital
dr lei zhao
dr jaffer ajani
esophagogastric cancers
esophagogastric
patient care
mayo clinic cancer center
hemtological malignancies
shaji kumar
care coordination
health care costs
access to medication
race and insurance disparities
healthcare costs
pharmaceutical trends
pharmaceutical oncology
pharmaceutical
value based care
long-term care
pharmacy
university of colorado health
selecthealth
famcp
eric cannon
bcop
pharmd
joseph kais
patient outcomes
urology cancer
university of texas
renal cell carcinoma
vegfr directed therapies
urology physicians
eric jonasch
hormone sensitive prostate cancer
cancer research
immunotherapeutic strategies for merkel cell
city of hope
therapy for mantle cell
michael wang
live cme meeting
koontz center for breast cancer
cn-bn
bsn
rn
janie metzker
breast cancer care
julia labarbera
koontz center for breast care
saint luke's hospital
parp inhibitors
monclonal antibodies
fnp-c
aprn
ms
abbey kaler
anderson cancer center
her2 inhibitors
tyrosine kinase
her2
phd
constance visovsky
cdk4/
julia lababera np
her2-low breast cancer
antibody drug conjugates
mcl
michael wang md
fellow cme
john theurer cancer center
cleveland clinic
taussig cancer institute
phyllis mckiernan
ipt
keith r mccrea
victoria sherry
maureen zakowski
mark socinski
vinflunine
urothelial carcinoma
ubc
pembrolizumab
paclitaxel
nyu langone
nivolumab
mibc
methotrexate
gemcitabine
erdafitinib
enfortumab vedotin
durvalumab
cisplatin
carboplatin
bladder cancer
axitinib
avelumab
atezolizumab
arjun balar
brenda martone
androgen deprivation therapy
adt
castration resistant prostate cancer
itp
allison imahiyerobo
james bussel
lymphoma
jamie chaft
driver mutations
advanced nsclc
mm
myeloma
immunoglobulin m
toni dubeau
morie gertz
nonhodgkin lymphoma
waldenstrom macrogolbulinemia
sara hurvitz
tnbc
allyson ocean
jaffer ajani
stomach cancer
metastatic gastric cancer
leslie smith
stephanie jackson
car t
car t-cell therapy
b cell malignancies
kami maddocks
craig moskowitz
alicia morgans
christopher flowers
fl
See more
Presentations
(30)Documents
(13)Personal Information
Organization / Workplace
Denville United States
Industry
Medical / Health Care / Pharmaceuticals
Website
www.i3Health.com
About
i3 Health's mission is to enhance the proficiency of the multidisciplinary cancer care team by providing evidence-based, fair-balanced CME/NCPD-approved activities that address identified professional practice gaps and unmet educational needs.
Tags
oncology
free cme
oncology nurse
cme
oncology physician
oncology education
oncology nursing society
ncpd
oncology cme
hematology
oncology nursing
continuing medical education
oncology fellows
cancer
oncologist
toxicity breast cancer
breast cancer
supportive care
breast cancer therapies
cpe
oncology and hematology
md
managing side effects
md anderson cancer center
multiple myeloma
prostate cancer
castration-resistant prostate cancer
crpc
nurse
physician
hematology fellow
physician education
treatment of multiple myeloma
ucla health
adverse event
immune thrombocytopenia
lung cancer
targeted therapy
metastatic breast cancer
immunotherapy
hodgkin lymphoma
tanya dorff
follicular lymphoma
hematologist
cancer education
nursing education
free ce
free ncpd
assuntina sacco
hnscc
head and neck scc
head and neck cancer
medical oncology
genitourinary cancer
urology
np
immune checkpoint inhibitors
mantle cell lymphoma
virtual tumor board
non small cell lung cancer
nsclc
anas younes
relapsed follicular lymphoma
sara tolaney
triple negative breast cancer
gastrointestinal oncology
gastric cancer
accme
tumor stage
radiation oncologist
clinical trials
early stage nsclc
msn
blanca ledezma
best practices
cancer immunotherapy
immune related adverse events
georgetown university medicine
catherine m broome
anemia cold-induced
strategies for anemia
safety and efficacy
diagnosis
cold agglutinin disease
attending faculty
faculty
hematology nurse
treatment
pathology
soft tissue sarcoma
advanced soft tissue sarcoma
education
breast pathology'
ira bleiweiss
dana farber cancer
tnbc therapies
breast oncology
spero cataland
acquired thrombotic thrombocyt
nanobodies in attp
anti-von willebrand factor
trials
attp
memorial sloan kettering
urvi shah
monoclonal antibodies
ndmm treatment
continuing education
medical education
free cne
metastatic disease
christopher lieu
colorectal cancer
her2-positive colorectal cance
bispecific t-cell
t-cell therapies
bcma-directed antibody -drug c
fred hutchinson cancer center
rahul banerjee
teaching resource
i3 health
ulka vaishampayan
oncology ncpd
mayo clinic
dr kelley rone
brigham women's hospital
dr lei zhao
dr jaffer ajani
esophagogastric cancers
esophagogastric
patient care
mayo clinic cancer center
hemtological malignancies
shaji kumar
care coordination
health care costs
access to medication
race and insurance disparities
healthcare costs
pharmaceutical trends
pharmaceutical oncology
pharmaceutical
value based care
long-term care
pharmacy
university of colorado health
selecthealth
famcp
eric cannon
bcop
pharmd
joseph kais
patient outcomes
urology cancer
university of texas
renal cell carcinoma
vegfr directed therapies
urology physicians
eric jonasch
hormone sensitive prostate cancer
cancer research
immunotherapeutic strategies for merkel cell
city of hope
therapy for mantle cell
michael wang
live cme meeting
koontz center for breast cancer
cn-bn
bsn
rn
janie metzker
breast cancer care
julia labarbera
koontz center for breast care
saint luke's hospital
parp inhibitors
monclonal antibodies
fnp-c
aprn
ms
abbey kaler
anderson cancer center
her2 inhibitors
tyrosine kinase
her2
phd
constance visovsky
cdk4/
julia lababera np
her2-low breast cancer
antibody drug conjugates
mcl
michael wang md
fellow cme
john theurer cancer center
cleveland clinic
taussig cancer institute
phyllis mckiernan
ipt
keith r mccrea
victoria sherry
maureen zakowski
mark socinski
vinflunine
urothelial carcinoma
ubc
pembrolizumab
paclitaxel
nyu langone
nivolumab
mibc
methotrexate
gemcitabine
erdafitinib
enfortumab vedotin
durvalumab
cisplatin
carboplatin
bladder cancer
axitinib
avelumab
atezolizumab
arjun balar
brenda martone
androgen deprivation therapy
adt
castration resistant prostate cancer
itp
allison imahiyerobo
james bussel
lymphoma
jamie chaft
driver mutations
advanced nsclc
mm
myeloma
immunoglobulin m
toni dubeau
morie gertz
nonhodgkin lymphoma
waldenstrom macrogolbulinemia
sara hurvitz
tnbc
allyson ocean
jaffer ajani
stomach cancer
metastatic gastric cancer
leslie smith
stephanie jackson
car t
car t-cell therapy
b cell malignancies
kami maddocks
craig moskowitz
alicia morgans
christopher flowers
fl
See more